ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

Abstract

.2. Drugs with unproven efficacy or no longer recommended . . 8.1.6.2.1. Digoxin . . . . . . . 8.1.6.2.2. Procainamide . . . . 8.1.6.2.3. Quinidine . . . . . . 8.1.6.2.4. Verapamil and diltiazem . . . . . . 8.1.7. Out-of-hospital initiation of antiarrhythmic drugs in patients with atrial fibrillation . . . . . .